Overview: HEV Detection PCR TestIntroduction: The HEV Detection PCR Test detects hepatitis E viral RNA to confirm infection, causing jaundice or liver pain. Following 2023 AASLD guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for patients with suspected hepatitis E, particularly in endemic areas or outbreak settings.
Other Names: HEV PCR Assay, Hepatitis E RNA Detection Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: HEV RNA testing began in the 2000s with PCR development. Qualitative PCR assays improved in the 2010s, enhancing infection confirmation.
Purpose: Confirms hepatitis E infection, guides treatment, and detects HEV RNA in patients with jaundice or liver pain.
Test Parameters: 1. HEV RNA (Qualitative)
Pretest Condition: No fasting required. Collect serum, plasma, or saliva at any time. Report symptoms like jaundice, liver pain, or fatigue, and list medications or travel history.
Specimen: 2-5 mL serum (SST), 2-4 mL plasma (EDTA), or 1-2 mL saliva (sterile container). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document jaundice, liver pain, fatigue, or travel to hepatitis E endemic areas. Include current medications and immunosuppression status.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for supportive care or treatment.
Procedural Considerations: Uses PCR to detect HEV RNA presence. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often in outbreak investigations.
Factors Affecting Result Accuracy: Improper sample handling, contamination, or low viral load can affect results. Immunosuppression may alter RNA detection.
Clinical Significance: Positive HEV RNA confirms active hepatitis E, prompting supportive care or treatment. Negative results may require repeat testing in early infection.
Specialist Consultation: Consult a hepatologist or infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Anti-HEV IgM, anti-HEV IgG, or liver function tests to confirm hepatitis E and assess liver damage.
Test Limitations: False negatives may occur in early infection or low viral load. Clinical correlation is needed.
References: AASLD Hepatitis E Guidelines, 2023; Hepatology, Kamar N, 2022.
